Iovance Biotherapeutics Inc. Common Stock vs Pan American Silver Corp. Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.63 (market cap $6.04B), while Pan American Silver Corp. Common Stock trades at $46.32 (market cap $18.72B). The key difference: Pan American Silver Corp. Common Stock is far larger — about 3.1× Iovance Biotherapeutics Inc. Common Stock's market cap, and Pan American Silver Corp. Common Stock pays a 1.62% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Pan American Silver Corp. Common Stock for 1 Days on average.
| IOVA | PAAS | |
|---|---|---|
Market Cap | $6.04B | $18.72B |
Volume | 14,805,993 | 2,957,838 |
Sector | Health | Basic Materials |
52-Week High | $14.82 | $68.70 |
52-Week Low | $1.81 | $33.20 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $5.97B | $17.86B |
Dividend Yield | — | 1.62% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →Pan American Silver is a mining company focused on silver and gold production in the Americas. It also explores and develops precious metals properties.
Read more on PAAS →